EP3695012
INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.10.2018:
8.3.2023:
18803806.1
:
10.10.2038
:
INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION
11.10.2018
8.3.2023
:
Regeneron Pharmaceuticals, Inc.:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
:
XIN, Yurong:
Tarrytown New York 10591, US
:
GROMADA, Jesper:
Tarrytown New York 10591, US
:
CHENG, Xiping:
Tarrytown New York 10591, US
:
DEWEY, Frederick:
Tarrytown New York 10591, US
:
TESLOVICH DOSTAL, Tanya:
Tarrytown New York 10591, US
:
SCHURMANN, Claudia:
Tarrytown New York 10591, US
:
BARAS, Aris:
Bedford Corners, New York 10549, US
:
ABUL-HUSN, Noura:
New York, NY 10128, US
:
201762570985 P:
11.10.2017:
US
:
US2018055377:
11.10.2018
:
C12Q 1/6883